Due to the rapid advancement and tremendous progress made in the study of lymphoma, the Lymphoma Research Foundation (LRF) offers a wide range of support services, educational programs, and free publications for people with lymphoma and their loved ones. Whether you are newly diagnosed, requesting information about your lymphoma subtype, looking for ongoing support, or seeking help with long-term survivorship, LRF is here to help.
LRF Education Resources
LRF offers a wide range of free disease-specific booklets and fact sheets for people with lymphoma, their loved ones, and healthcare professionals.LEARN MORE
LRF hosts several in-person patient education conferences and programs in order to provide members of the lymphoma community with up-to-date information.LEARN MORE
LRF offers disease-specific learning centers which provide diagnostic information, treatment options, and resources.LEARN MORE
LRF’s mobile app, Focus on Lymphoma, provides unlimited access to lymphoma information and health care tools right at your fingertips.LEARN MORE
LRF’s free teleconferences are hour-long interactive programs led by leading lymphoma experts who discuss lymphoma, treatment options, clinical trials and promising innovative research.LEARN MORE
The LRF Helpline staff is available to provide individualized information on types of lymphoma diagnostic tests, treatment options, potential side effects, and the latest in research to more than 10,000 patients and caregivers each year.
Helpline services include:
- Provide patients and caregivers with a list of questions to ask their healthcare team
- Conduct customized clinical trial searchs and provide a list of potential tirals and questions patients and their caregivers can discuss with their healthcare team
- Connect patients and caregivers with financial resources and legal and insurance help
Contact the LRF Helpline toll-free at 800-500-9976 or email at email@example.com with any of your lymphoma-related questions, Monday through Friday from 9:30am – 7:30pm Eastern Standard Time (ET).